However, similar to our results, more recent studies using expression array-based survival curves found that a high GJA1 expression was associated with a better prognosis in ERα-positive breast cancer tumors, while an opposite trend was observed in ERα-negative tumors [33] and Her2e tumors [34]. This evidence concerns the gene ESR1 and breast carcinoma.